Cargando…

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

PURPOSE: Patients with pancreatic cancer often receive radiation therapy before undergoing surgical resection. We compared the clinical outcomes differences between stereotactic body radiation therapy (SBRT) and 3-dimensional (3D)/intensity-modulated radiation therapy (IMRT). METHODS AND MATERIALS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abi Jaoude, Joseph, Thunshelle, Connor P., Kouzy, Ramez, Nguyen, Nicholas D., Lin, Daniel, Prakash, Laura, Bumanlag, Isabela M., Noticewala, Sonal S., Niedzielski, Joshua S., Beddar, Sam, Ludmir, Ethan B., Holliday, Emma B., Das, Prajnan, Minsky, Bruce D., Herman, Joseph M., Katz, Matthew, Koong, Albert C., Koay, Eugene J., Taniguchi, Cullen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655391/ https://www.ncbi.nlm.nih.gov/pubmed/34934858 http://dx.doi.org/10.1016/j.adro.2021.100763

Ejemplares similares

Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020)

Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020)

Applying to Radiation Oncology Amid a Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020)

Exclusion of Older Adults in COVID-19 Clinical Trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2020)

Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Microbiome factors in HPV-driven carcinogenesis and cancers
por: Lin, Daniel, et al.
Publicado: (2020)

Impact factor and citation metrics in phase III cancer trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
por: Cazacu, Irina M., et al.
Publicado: (2023)

Professional Medical Writer Assistance in Oncology Clinical Trials
por: Kouzy, Ramez, et al.
Publicado: (2020)

Food and Drug Administration approvals in phase 3 Cancer clinical trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration–based image guidance
por: Choi, Gye Won, et al.
Publicado: (2019)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Colbert, Lauren E., et al.
Publicado: (2018)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
por: Florez, Marcus A., et al.
Publicado: (2023)

Inclusion of premenopausal women in breast cancer clinical trials
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
por: De, Brian, et al.
Publicado: (2021)

Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity
por: Lin, Daniel, et al.
Publicado: (2021)

In Reply to Rathod et al
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials
por: Patel, Roshal R., et al.
Publicado: (2022)

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network
por: Augustyn, Alexander, et al.
Publicado: (2021)

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma
por: Manzar, Gohar Shahwar, et al.
Publicado: (2022)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
por: Hernandez, Sharia, et al.
Publicado: (2023)

Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter
por: Kouzy, Ramez, et al.
Publicado: (2020)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer
por: Wang, Charles X., et al.
Publicado: (2022)

Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus
por: Holliday, Emma B., et al.
Publicado: (2017)

Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6hl7a13nm84jtr1gm7oul4rr8